

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 7.60926129 |
| 2 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.22223970 |
| 3 | positive T cell selection (GO:0043368) | 6.99659418 |
| 4 | negative T cell selection (GO:0043383) | 6.80987987 |
| 5 | positive thymic T cell selection (GO:0045059) | 6.26279127 |
| 6 | DNA deamination (GO:0045006) | 5.96063785 |
| 7 | cytidine metabolic process (GO:0046087) | 5.80690320 |
| 8 | cytidine catabolic process (GO:0006216) | 5.80690320 |
| 9 | cytidine deamination (GO:0009972) | 5.80690320 |
| 10 | regulation of B cell differentiation (GO:0045577) | 5.75406900 |
| 11 | negative thymic T cell selection (GO:0045060) | 5.48501312 |
| 12 | positive regulation of B cell differentiation (GO:0045579) | 5.47498692 |
| 13 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.32025063 |
| 14 | T cell selection (GO:0045058) | 5.22422523 |
| 15 | regulation of alpha-beta T cell proliferation (GO:0046640) | 5.16026283 |
| 16 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.12853882 |
| 17 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 5.09637085 |
| 18 | thymic T cell selection (GO:0045061) | 5.06324017 |
| 19 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.96463678 |
| 20 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.69421129 |
| 21 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.62209475 |
| 22 | leukocyte aggregation (GO:0070486) | 4.52467409 |
| 23 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.44540945 |
| 24 | Peyers patch development (GO:0048541) | 4.44540945 |
| 25 | positive regulation of tolerance induction (GO:0002645) | 4.23830235 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.21904094 |
| 27 | positive regulation of macrophage differentiation (GO:0045651) | 4.20373822 |
| 28 | negative regulation of B cell apoptotic process (GO:0002903) | 4.19530921 |
| 29 | regulation of T cell tolerance induction (GO:0002664) | 4.17502284 |
| 30 | T cell migration (GO:0072678) | 4.16197836 |
| 31 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.10489346 |
| 32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.09531800 |
| 33 | T cell costimulation (GO:0031295) | 4.09336288 |
| 34 | negative regulation of T cell apoptotic process (GO:0070233) | 4.09213854 |
| 35 | lymphocyte costimulation (GO:0031294) | 4.04112059 |
| 36 | T cell receptor signaling pathway (GO:0050852) | 4.01775997 |
| 37 | negative regulation by host of viral transcription (GO:0043922) | 4.00499022 |
| 38 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.00172375 |
| 39 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.97969343 |
| 40 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.79295269 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.76343309 |
| 42 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.75863041 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.75731159 |
| 44 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.73555039 |
| 45 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.67301726 |
| 46 | cellular response to interleukin-15 (GO:0071350) | 3.62483040 |
| 47 | positive regulation of lymphocyte migration (GO:2000403) | 3.62143140 |
| 48 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.61287516 |
| 49 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.60133777 |
| 50 | negative regulation of B cell proliferation (GO:0030889) | 3.57901367 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.57585740 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.57085147 |
| 53 | positive regulation of granulocyte differentiation (GO:0030854) | 3.54650392 |
| 54 | deoxyribonucleotide catabolic process (GO:0009264) | 3.54371344 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.52036327 |
| 56 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.44932890 |
| 57 | deoxyribose phosphate catabolic process (GO:0046386) | 3.40660139 |
| 58 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.40124282 |
| 59 | mature B cell differentiation (GO:0002335) | 3.37675012 |
| 60 | regulation of activation of Janus kinase activity (GO:0010533) | 3.35397151 |
| 61 | regulation of B cell apoptotic process (GO:0002902) | 3.31700474 |
| 62 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.31103447 |
| 63 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.31097750 |
| 64 | negative regulation of cell killing (GO:0031342) | 3.31097750 |
| 65 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.30005889 |
| 66 | response to interleukin-15 (GO:0070672) | 3.28808827 |
| 67 | purine nucleotide salvage (GO:0032261) | 3.25265493 |
| 68 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.24686516 |
| 69 | actin nucleation (GO:0045010) | 3.18390188 |
| 70 | negative regulation of B cell activation (GO:0050869) | 3.17572926 |
| 71 | regulation of calcium-mediated signaling (GO:0050848) | 3.15451955 |
| 72 | B cell mediated immunity (GO:0019724) | 3.15020655 |
| 73 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.12949037 |
| 74 | positive regulation of defense response to virus by host (GO:0002230) | 3.11361992 |
| 75 | positive regulation of interleukin-2 production (GO:0032743) | 3.10232262 |
| 76 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.09060899 |
| 77 | regulation of alpha-beta T cell activation (GO:0046634) | 3.09054529 |
| 78 | regulation of lymphocyte apoptotic process (GO:0070228) | 3.08621190 |
| 79 | regulation of B cell activation (GO:0050864) | 3.07347977 |
| 80 | regulation of T cell apoptotic process (GO:0070232) | 3.06146188 |
| 81 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.05506527 |
| 82 | regulation of gamma-delta T cell activation (GO:0046643) | 3.02138161 |
| 83 | regulation of macrophage differentiation (GO:0045649) | 2.97897479 |
| 84 | immunoglobulin mediated immune response (GO:0016064) | 2.97134710 |
| 85 | cellular response to type I interferon (GO:0071357) | 2.95090136 |
| 86 | type I interferon signaling pathway (GO:0060337) | 2.95090136 |
| 87 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.94506908 |
| 88 | positive regulation of lamellipodium assembly (GO:0010592) | 2.91387719 |
| 89 | negative regulation of interleukin-12 production (GO:0032695) | 2.90469148 |
| 90 | response to type I interferon (GO:0034340) | 2.90356683 |
| 91 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.88710644 |
| 92 | regulation of lymphocyte migration (GO:2000401) | 2.88376086 |
| 93 | autophagic vacuole fusion (GO:0000046) | 2.85121234 |
| 94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.85013752 |
| 95 | response to interferon-beta (GO:0035456) | 2.82217511 |
| 96 | regulation of B cell proliferation (GO:0030888) | 2.79806733 |
| 97 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.78877159 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.75364774 |
| 99 | positive regulation of T cell activation (GO:0050870) | 2.74622800 |
| 100 | purine-containing compound salvage (GO:0043101) | 2.73767285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.68209942 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.79065493 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.71854190 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.59506469 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.28994654 |
| 6 | MYB_26560356_Chip-Seq_TH2_Human | 3.22020647 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.09990639 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.06249610 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.98356240 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.92762889 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.66018902 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.65720964 |
| 13 | UTX_26944678_Chip-Seq_JUKART_Human | 2.60618711 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53003435 |
| 15 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35113133 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.31074107 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.20881706 |
| 18 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.15345601 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14531044 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.10979390 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.09329138 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.07877297 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.05582236 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04876041 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03448178 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99235478 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 1.98935926 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.96933792 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96213248 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93774329 |
| 31 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.91845134 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81785173 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80672209 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75214184 |
| 35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.68484053 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58954792 |
| 37 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.57624009 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49927210 |
| 39 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49805921 |
| 40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48448844 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39330552 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38572459 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34149678 |
| 44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33847523 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33621687 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33224305 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29551014 |
| 48 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.29500358 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25424544 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21408890 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20960935 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17324425 |
| 53 | P300_27268052_Chip-Seq_Bcells_Human | 1.15045756 |
| 54 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.12786421 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12630922 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12572823 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09162601 |
| 58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08233510 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08182565 |
| 60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07760826 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04956496 |
| 62 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04220090 |
| 63 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04135938 |
| 64 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03589739 |
| 65 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03175251 |
| 66 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.02307144 |
| 67 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.01595659 |
| 68 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.00336865 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00132066 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99769108 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99059077 |
| 72 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98476518 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98425754 |
| 74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98354389 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96744751 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96713836 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95961137 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95732617 |
| 79 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.95447542 |
| 80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95243354 |
| 81 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94674875 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94480266 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92556513 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92354011 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.91197840 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90648701 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90541668 |
| 88 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.90415712 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90382657 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89212049 |
| 91 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.86880026 |
| 92 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85082631 |
| 93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.84200417 |
| 94 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.81460501 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81240745 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78963031 |
| 97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78500150 |
| 98 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.78114928 |
| 99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77426104 |
| 100 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.77021886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.04784289 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.31882367 |
| 3 | MP0002009_preneoplasia | 4.15927054 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.81244558 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.27744282 |
| 6 | MP0002166_altered_tumor_susceptibility | 3.13491419 |
| 7 | MP0001800_abnormal_humoral_immune | 3.00130911 |
| 8 | MP0001873_stomach_inflammation | 2.76648435 |
| 9 | MP0002420_abnormal_adaptive_immunity | 2.70945629 |
| 10 | MP0005387_immune_system_phenotype | 2.64236122 |
| 11 | MP0001790_abnormal_immune_system | 2.64236122 |
| 12 | MP0001819_abnormal_immune_cell | 2.63568718 |
| 13 | MP0002723_abnormal_immune_serum | 2.59424359 |
| 14 | MP0002398_abnormal_bone_marrow | 2.53974723 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 2.40539601 |
| 16 | MP0006082_CNS_inflammation | 2.37372479 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.36303395 |
| 18 | MP0002006_tumorigenesis | 2.35546258 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.33506758 |
| 20 | MP0003436_decreased_susceptibility_to | 2.31623078 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.30586598 |
| 22 | MP0002933_joint_inflammation | 2.28381696 |
| 23 | MP0000716_abnormal_immune_system | 2.21285206 |
| 24 | MP0002405_respiratory_system_inflammati | 2.13594187 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.09809731 |
| 26 | MP0005025_abnormal_response_to | 2.07730549 |
| 27 | MP0005451_abnormal_body_composition | 2.04565927 |
| 28 | MP0003724_increased_susceptibility_to | 1.96471300 |
| 29 | MP0009785_altered_susceptibility_to | 1.93576078 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.89235055 |
| 31 | MP0002722_abnormal_immune_system | 1.84804331 |
| 32 | MP0002419_abnormal_innate_immunity | 1.76354574 |
| 33 | MP0002429_abnormal_blood_cell | 1.74701218 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.70057714 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.69695685 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.65485324 |
| 37 | MP0000685_abnormal_immune_system | 1.57137033 |
| 38 | MP0009384_cardiac_valve_regurgitation | 1.49725776 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.48180015 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.47014927 |
| 41 | MP0001853_heart_inflammation | 1.35026051 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.34541498 |
| 43 | MP0003866_abnormal_defecation | 1.26158963 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.24985025 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.24796700 |
| 46 | MP0009278_abnormal_bone_marrow | 1.22900786 |
| 47 | MP0006072_abnormal_retinal_apoptosis | 1.20203941 |
| 48 | MP0009697_abnormal_copulation | 1.20116697 |
| 49 | MP0003252_abnormal_bile_duct | 1.19769395 |
| 50 | MP0000858_altered_metastatic_potential | 1.12600519 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.12142621 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.10946493 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.10946493 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.08830758 |
| 55 | MP0009764_decreased_sensitivity_to | 1.08062309 |
| 56 | MP0004381_abnormal_hair_follicle | 1.06634492 |
| 57 | MP0008469_abnormal_protein_level | 1.05914133 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.05072784 |
| 59 | MP0004947_skin_inflammation | 1.05003795 |
| 60 | MP0002019_abnormal_tumor_incidence | 1.03349602 |
| 61 | MP0004142_abnormal_muscle_tone | 1.00077089 |
| 62 | MP0003646_muscle_fatigue | 0.99977972 |
| 63 | MP0003303_peritoneal_inflammation | 0.98628210 |
| 64 | MP0005310_abnormal_salivary_gland | 0.96837321 |
| 65 | MP0001984_abnormal_olfaction | 0.95964039 |
| 66 | MP0002928_abnormal_bile_duct | 0.85202669 |
| 67 | MP0009763_increased_sensitivity_to | 0.84460697 |
| 68 | MP0001533_abnormal_skeleton_physiology | 0.83778003 |
| 69 | MP0003448_altered_tumor_morphology | 0.82833087 |
| 70 | MP0003787_abnormal_imprinting | 0.82701245 |
| 71 | MP0002132_abnormal_respiratory_system | 0.81082002 |
| 72 | MP0000013_abnormal_adipose_tissue | 0.81073822 |
| 73 | MP0001764_abnormal_homeostasis | 0.80182043 |
| 74 | MP0005410_abnormal_fertilization | 0.78977062 |
| 75 | MP0005646_abnormal_pituitary_gland | 0.76335499 |
| 76 | MP0001663_abnormal_digestive_system | 0.75817967 |
| 77 | MP0008004_abnormal_stomach_pH | 0.75033575 |
| 78 | MP0001905_abnormal_dopamine_level | 0.74113188 |
| 79 | MP0008872_abnormal_physiological_respon | 0.71949996 |
| 80 | MP0008058_abnormal_DNA_repair | 0.71905355 |
| 81 | MP0008873_increased_physiological_sensi | 0.71460107 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.70350355 |
| 83 | MP0001661_extended_life_span | 0.70304449 |
| 84 | MP0001881_abnormal_mammary_gland | 0.69449862 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.64797993 |
| 86 | MP0001968_abnormal_touch/_nociception | 0.62539658 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 0.61116289 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 0.59931316 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.59291863 |
| 90 | MP0005253_abnormal_eye_physiology | 0.56902934 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.56778069 |
| 92 | MP0002163_abnormal_gland_morphology | 0.55935807 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.55264332 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.53584632 |
| 95 | MP0008569_lethality_at_weaning | 0.53455555 |
| 96 | MP0004147_increased_porphyrin_level | 0.52905247 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 0.52097027 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.51847982 |
| 99 | MP0000249_abnormal_blood_vessel | 0.49272809 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.48113706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.77832493 |
| 2 | Panhypogammaglobulinemia (HP:0003139) | 6.23204749 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 6.00877975 |
| 4 | Aplastic anemia (HP:0001915) | 5.99422118 |
| 5 | Autoimmune hemolytic anemia (HP:0001890) | 5.74901848 |
| 6 | Agammaglobulinemia (HP:0004432) | 5.71194075 |
| 7 | Combined immunodeficiency (HP:0005387) | 4.82754404 |
| 8 | Recurrent viral infections (HP:0004429) | 4.46233178 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.30521357 |
| 10 | T lymphocytopenia (HP:0005403) | 4.25710964 |
| 11 | B lymphocytopenia (HP:0010976) | 4.19922946 |
| 12 | Hypoproteinemia (HP:0003075) | 4.19646630 |
| 13 | Granulocytopenia (HP:0001913) | 4.18984749 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 4.09240597 |
| 15 | Encephalitis (HP:0002383) | 3.99455649 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.98690241 |
| 17 | Increased IgE level (HP:0003212) | 3.97222968 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.95042792 |
| 19 | Abnormality of T cells (HP:0002843) | 3.93841131 |
| 20 | Eosinophilia (HP:0001880) | 3.92371670 |
| 21 | Abnormality of B cell number (HP:0010975) | 3.88108455 |
| 22 | Meningitis (HP:0001287) | 3.82901389 |
| 23 | Abnormality of eosinophils (HP:0001879) | 3.66393638 |
| 24 | Thyroiditis (HP:0100646) | 3.63189589 |
| 25 | Hypoplasia of the thymus (HP:0000778) | 3.52214995 |
| 26 | Lymphopenia (HP:0001888) | 3.51095237 |
| 27 | Increased IgM level (HP:0003496) | 3.44292576 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.42394847 |
| 29 | Hypergammaglobulinemia (HP:0010702) | 3.38908713 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.32703204 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.32703204 |
| 32 | Myositis (HP:0100614) | 3.29194690 |
| 33 | Leukocytosis (HP:0001974) | 3.24982420 |
| 34 | IgG deficiency (HP:0004315) | 3.24911880 |
| 35 | Stomatitis (HP:0010280) | 3.22835892 |
| 36 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.21095903 |
| 37 | IgM deficiency (HP:0002850) | 3.05681194 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 3.00963274 |
| 39 | Obstructive lung disease (HP:0006536) | 2.96238487 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 2.96238487 |
| 41 | Neonatal respiratory distress (HP:0002643) | 2.92891580 |
| 42 | Fatigue (HP:0012378) | 2.82989158 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.79823541 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.78175971 |
| 45 | Hemiplegia (HP:0002301) | 2.75609755 |
| 46 | Abnormality of the prostate (HP:0008775) | 2.74936759 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.69845443 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.69175563 |
| 49 | Lymphoma (HP:0002665) | 2.68800680 |
| 50 | Oral leukoplakia (HP:0002745) | 2.66568689 |
| 51 | Vasculitis (HP:0002633) | 2.64682872 |
| 52 | Sepsis (HP:0100806) | 2.34758092 |
| 53 | Neutropenia (HP:0001875) | 2.34323866 |
| 54 | Recurrent abscess formation (HP:0002722) | 2.33281282 |
| 55 | Abnormality of macrophages (HP:0004311) | 2.32714264 |
| 56 | Recurrent skin infections (HP:0001581) | 2.32239818 |
| 57 | Congenital stationary night blindness (HP:0007642) | 2.30483414 |
| 58 | Chronic diarrhea (HP:0002028) | 2.29594986 |
| 59 | Recurrent bacterial skin infections (HP:0005406) | 2.27495767 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.25963617 |
| 61 | Optic neuritis (HP:0100653) | 2.25963617 |
| 62 | Mesangial abnormality (HP:0001966) | 2.24728284 |
| 63 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.18975454 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.18925941 |
| 65 | Orchitis (HP:0100796) | 2.18307348 |
| 66 | Recurrent bronchitis (HP:0002837) | 2.17794159 |
| 67 | Recurrent lower respiratory tract infections (HP:0002783) | 2.15945466 |
| 68 | Chest pain (HP:0100749) | 2.14077245 |
| 69 | Amyotrophic lateral sclerosis (HP:0007354) | 2.08961844 |
| 70 | Cellulitis (HP:0100658) | 2.05389067 |
| 71 | Pustule (HP:0200039) | 1.99502722 |
| 72 | Pulmonary infiltrates (HP:0002113) | 1.98797481 |
| 73 | Opisthotonus (HP:0002179) | 1.97184781 |
| 74 | Pancytopenia (HP:0001876) | 1.96856080 |
| 75 | Verrucae (HP:0200043) | 1.95839969 |
| 76 | Papilloma (HP:0012740) | 1.95839969 |
| 77 | Skin rash (HP:0000988) | 1.95423902 |
| 78 | Colitis (HP:0002583) | 1.92517146 |
| 79 | Viral hepatitis (HP:0006562) | 1.87676238 |
| 80 | Gangrene (HP:0100758) | 1.87484367 |
| 81 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.85839334 |
| 82 | Cellular immunodeficiency (HP:0005374) | 1.83765058 |
| 83 | Recurrent pneumonia (HP:0006532) | 1.78292647 |
| 84 | Epistaxis (HP:0000421) | 1.76886101 |
| 85 | Recurrent otitis media (HP:0000403) | 1.76449390 |
| 86 | Chronic sinusitis (HP:0011109) | 1.76050014 |
| 87 | Joint swelling (HP:0001386) | 1.75885171 |
| 88 | Abnormality of male internal genitalia (HP:0000022) | 1.74407261 |
| 89 | Erythema (HP:0010783) | 1.73843813 |
| 90 | Hypertensive crisis (HP:0100735) | 1.69241593 |
| 91 | Hemoptysis (HP:0002105) | 1.69006315 |
| 92 | Abnormality of the pleura (HP:0002103) | 1.67637456 |
| 93 | Petechiae (HP:0000967) | 1.64366950 |
| 94 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.63499572 |
| 95 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.62569942 |
| 96 | Recurrent sinusitis (HP:0011108) | 1.62038017 |
| 97 | Abnormality of alanine metabolism (HP:0010916) | 1.59347624 |
| 98 | Hyperalaninemia (HP:0003348) | 1.59347624 |
| 99 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.59347624 |
| 100 | Spontaneous hematomas (HP:0007420) | 1.57907634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.98575147 |
| 2 | KDR | 4.71592390 |
| 3 | TAOK3 | 3.88160904 |
| 4 | TESK2 | 3.57103735 |
| 5 | MAP3K11 | 3.31287929 |
| 6 | SCYL2 | 3.10312596 |
| 7 | TXK | 3.04238786 |
| 8 | ITK | 2.67642292 |
| 9 | BTK | 2.11493358 |
| 10 | KIT | 2.11241963 |
| 11 | TNK2 | 2.02110541 |
| 12 | RIPK4 | 1.95691259 |
| 13 | SYK | 1.93149371 |
| 14 | CDK19 | 1.75800525 |
| 15 | CSF1R | 1.69539344 |
| 16 | IRAK2 | 1.69076717 |
| 17 | FES | 1.62337378 |
| 18 | PRKCQ | 1.58630738 |
| 19 | BCKDK | 1.58574616 |
| 20 | NME2 | 1.58366346 |
| 21 | TEC | 1.58255371 |
| 22 | TBK1 | 1.55799015 |
| 23 | LCK | 1.51742402 |
| 24 | ZAP70 | 1.49234896 |
| 25 | CSK | 1.39965654 |
| 26 | JAK3 | 1.38690656 |
| 27 | GRK6 | 1.36451482 |
| 28 | LYN | 1.25941798 |
| 29 | IKBKE | 1.16767046 |
| 30 | CDK12 | 1.16070081 |
| 31 | TYK2 | 1.15680812 |
| 32 | PIM1 | 1.13230804 |
| 33 | HCK | 1.08028154 |
| 34 | BMPR2 | 1.07789771 |
| 35 | TAOK1 | 1.07449495 |
| 36 | MAP2K3 | 1.06619508 |
| 37 | PRKCH | 1.05938898 |
| 38 | CCNB1 | 1.05754486 |
| 39 | VRK2 | 1.05574163 |
| 40 | TESK1 | 1.04741419 |
| 41 | MARK3 | 1.04399907 |
| 42 | MAP4K2 | 1.02415823 |
| 43 | MAP3K3 | 1.01747997 |
| 44 | MAPKAPK3 | 0.92570667 |
| 45 | IRAK4 | 0.90652170 |
| 46 | CDK9 | 0.86972100 |
| 47 | IKBKB | 0.84322560 |
| 48 | TAOK2 | 0.79992524 |
| 49 | CDK4 | 0.70036907 |
| 50 | CDK8 | 0.69036740 |
| 51 | VRK1 | 0.67048053 |
| 52 | DYRK1B | 0.66817542 |
| 53 | MAPK11 | 0.65980180 |
| 54 | IRAK1 | 0.64962535 |
| 55 | GRK1 | 0.64699905 |
| 56 | ADRBK2 | 0.62556811 |
| 57 | FLT3 | 0.61925216 |
| 58 | ZAK | 0.61656955 |
| 59 | CDK3 | 0.57028615 |
| 60 | TRPM7 | 0.56857824 |
| 61 | FYN | 0.53926427 |
| 62 | PIM2 | 0.52732612 |
| 63 | MAP3K7 | 0.49707944 |
| 64 | CAMKK2 | 0.49162285 |
| 65 | BUB1 | 0.48985170 |
| 66 | CDC7 | 0.48783560 |
| 67 | MAPK12 | 0.48741915 |
| 68 | MATK | 0.47325695 |
| 69 | UHMK1 | 0.46800772 |
| 70 | AKT3 | 0.44866082 |
| 71 | MAP2K6 | 0.43910064 |
| 72 | PRKD2 | 0.43898221 |
| 73 | PASK | 0.43804275 |
| 74 | JAK1 | 0.43657100 |
| 75 | DAPK1 | 0.43300197 |
| 76 | LRRK2 | 0.43191492 |
| 77 | CDK6 | 0.42333330 |
| 78 | HIPK2 | 0.38212437 |
| 79 | TGFBR2 | 0.36625395 |
| 80 | INSR | 0.35959122 |
| 81 | NLK | 0.35885866 |
| 82 | AURKA | 0.35703504 |
| 83 | SIK2 | 0.35209974 |
| 84 | MAPK13 | 0.32274385 |
| 85 | NUAK1 | 0.31261483 |
| 86 | PIK3CG | 0.30225703 |
| 87 | IGF1R | 0.29311049 |
| 88 | ABL1 | 0.29037543 |
| 89 | PRKCA | 0.26004996 |
| 90 | BLK | 0.25994436 |
| 91 | MAPK3 | 0.25537942 |
| 92 | RPS6KA1 | 0.25532913 |
| 93 | PDK1 | 0.25255368 |
| 94 | MAPKAPK2 | 0.24421051 |
| 95 | PRKD1 | 0.24228161 |
| 96 | FGR | 0.23711400 |
| 97 | CAMKK1 | 0.23513793 |
| 98 | MAPK15 | 0.23324583 |
| 99 | INSRR | 0.21424744 |
| 100 | STK10 | 0.18719079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.39377925 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.69898387 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.54669624 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.52904761 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.91810431 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.69313877 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.67816158 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.63676183 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.61819452 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.52768418 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.51805300 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21701598 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.19975347 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05452169 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.97059442 |
| 16 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.90293514 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.80955169 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.73588219 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68796780 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63394040 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58385575 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.51643497 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.48302517 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.48025710 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44249855 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37608377 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34441656 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.28342487 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.26515058 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.25581972 |
| 31 | Ribosome_Homo sapiens_hsa03010 | 1.21376277 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.18047281 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08459044 |
| 34 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.08218361 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00619303 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95856498 |
| 37 | DNA replication_Homo sapiens_hsa03030 | 0.92902307 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91038139 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82899342 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81515505 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 0.79229622 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77771476 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.73164089 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73015000 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 0.70485978 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70274028 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 0.70220837 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66233808 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65981662 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.65935783 |
| 51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65708876 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.62667747 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.61932086 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57569337 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57224510 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.54496923 |
| 57 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53315583 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51051999 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50789192 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50440788 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50292828 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47205366 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.47040961 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46688545 |
| 65 | Base excision repair_Homo sapiens_hsa03410 | 0.46092509 |
| 66 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45869170 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.45858739 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43903591 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43171624 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41344401 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40999699 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40432730 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40141461 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.40067502 |
| 75 | Mismatch repair_Homo sapiens_hsa03430 | 0.39194802 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37798005 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37055729 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36432673 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.36070060 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34602001 |
| 81 | Spliceosome_Homo sapiens_hsa03040 | 0.33390343 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.31866687 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31589378 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29792585 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28774170 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28074590 |
| 87 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.28069757 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27869909 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27736409 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.26286790 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.20671736 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.20429066 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20417910 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.20375464 |
| 95 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.17930969 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.16207943 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14229895 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.13375627 |
| 99 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.12481119 |
| 100 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.11309353 |

